Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CADL Candel Therapeutics > Detailed Quotes

CADL Candel Therapeutics

Watchlist
2.420
+0.080+3.42%
Close  02/03 16:00 ET
2.4350.0000.00%
Post Mkt Price 02/03 16:00 ET
High
2.520
Open
2.510
Turnover
34.76K
Low
2.350
Pre Close
2.340
Volume
14.47K
Market Cap
69.92M
P/E(TTM)
Loss
52wk High
5.750
Shares
28.89M
P/E(Static)
Loss
52wk Low
1.400
Float Cap
31.21M
Bid/Ask %
-20.00%
Historical High
14.780
Shs Float
12.90M
Volume Ratio
0.58
Historical Low
1.400
Dividend TTM
--
Div Yield TTM
--
P/B
1.34
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.11%
Amplitude
7.27%
Avg Price
2.402
Lot Size
1
Float Cap
31.21M
Bid/Ask %
-20.00%
Historical High
14.780
Shs Float
12.90M
Volume Ratio
0.58
Historical Low
1.400
Dividend TTM
--
P/B
1.34
Dividend LFY
--
Turnover Ratio
0.11%
Amplitude
7.27%
Avg Price
2.402
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
CEO: Dr. Paul Peter Tak, M.D.,PhD
Market: NASDAQ
Listing Date: 07/27/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist